These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30615445)

  • 21. Emerging roles of secreted phospholipase A2 enzymes: the 3rd edition.
    Murakami M; Taketomi Y; Miki Y; Sato H; Yamamoto K; Lambeau G
    Biochimie; 2014 Dec; 107 Pt A():105-13. PubMed ID: 25230085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Competitive inhibition of lipolytic enzymes. III. Some acylamino analogues of phospholipids are potent competitive inhibitors of porcine pancreatic phospholipase A2.
    de Haas GH; Dijkman R; van Oort MG; Verger R
    Biochim Biophys Acta; 1990 Mar; 1043(1):75-82. PubMed ID: 2310763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.
    Mouchlis VD; Limnios D; Kokotou MG; Barbayianni E; Kokotos G; McCammon JA; Dennis EA
    J Med Chem; 2016 May; 59(9):4403-14. PubMed ID: 27087127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A beta-lactam inhibitor of cytosolic phospholipase A2 which acts in a competitive, reversible manner at the lipid/water interface.
    Burke JR; Gregor KR; Padmanabha R; Banville J; Witmer MR; Davern LB; Manly SP; Tramposch KM
    J Enzyme Inhib; 1998 Jun; 13(3):195-206. PubMed ID: 9629537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phospholipid peroxidation induces cytosolic phospholipase A2 activity: membrane effects versus enzyme phosphorylation.
    Rashba-Step J; Tatoyan A; Duncan R; Ann D; Pushpa-Rehka TR; Sevanian A
    Arch Biochem Biophys; 1997 Jul; 343(1):44-54. PubMed ID: 9210645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory aspects of mitochondrial phospholipase A2: correlation of hydrolysis rates with substrate configuration as evidenced by 31P-NMR.
    Lenting HB; Nicolay K; van den Bosch H
    Biochim Biophys Acta; 1988 Feb; 958(3):405-15. PubMed ID: 3342248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the catalytic activity of phospholipase A2: E. coli-based assay compared to a photometric micelle assay.
    Aufenanger J; Zimmer W; Püttmann M; Ensenauer R
    Eur J Clin Chem Clin Biochem; 1993 Nov; 31(11):777-85. PubMed ID: 7508272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalytic Ca2+-binding site of pancreatic phospholipase A2: laser-induced Eu3+ luminescence study.
    van Scharrenburg GJ; Slotboom AJ; de Haas GH; Mulqueen P; Breen PJ; Horrocks WD
    Biochemistry; 1985 Jan; 24(2):334-9. PubMed ID: 3978077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
    Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
    Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
    Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship studies on 1-(2-oxopropyl)indole-5-carboxylic acids acting as inhibitors of cytosolic phospholipase A
    Arnsmann M; Hanekamp W; Elfringhoff AS; Lehr M
    Eur J Med Chem; 2017 Jan; 125():1107-1114. PubMed ID: 27810597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of secreted phospholipases A2 by annexin V. Competition for anionic phospholipid interfaces allows an assessment of the relative interfacial affinities of secreted phospholipases A2.
    Buckland AG; Wilton DC
    Biochim Biophys Acta; 1998 Apr; 1391(3):367-76. PubMed ID: 9555096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interfacial catalysis by phospholipase A2: the rate-limiting step for enzymatic turnover.
    Jain MK; Yu BZ; Rogers J; Gelb MH; Tsai MD; Hendrickson EK; Hendrickson HS
    Biochemistry; 1992 Sep; 31(34):7841-7. PubMed ID: 1510970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selectivity of cytosolic phospholipase A2 type IV toward arachidonyl phospholipids.
    Grandits M; Oostenbrink C
    J Mol Recognit; 2015 Jul; 28(7):447-57. PubMed ID: 25703463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic basis for the substrate specificity during hydrolysis of phospholipids by secreted phospholipase A2.
    Rogers J; Yu BZ; Serves SV; Tsivgoulis GM; Sotiropoulos DN; Ioannou PV; Jain MK
    Biochemistry; 1996 Jul; 35(29):9375-84. PubMed ID: 8755715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium-dependent and -independent interfacial binding and catalysis of cytosolic group IV phospholipase A2.
    Hixon MS; Ball A; Gelb MH
    Biochemistry; 1998 Jun; 37(23):8516-26. PubMed ID: 9622504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of phospholipase A2 action toward mixed micelles of detergent and phospholipids.
    Dennis EA
    Adv Exp Med Biol; 1978; 101():165-75. PubMed ID: 665362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the propeptide of group X secreted phospholipase A(2) on substrate specificity and interfacial activity on phospholipid monolayers.
    Point V; Bénarouche A; Jemel I; Parsiegla G; Lambeau G; Carrière F; Cavalier JF
    Biochimie; 2013 Jan; 95(1):51-8. PubMed ID: 22967966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretory phospholipase A2 activity toward diverse substrates.
    Madsen JJ; Linderoth L; Subramanian AK; Andresen TL; Peters GH
    J Phys Chem B; 2011 Jun; 115(21):6853-61. PubMed ID: 21561115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application of rational design on phospholipase A(2) inhibitors.
    Mouchlis VD; Barbayianni E; Mavromoustakos TM; Kokotos G
    Curr Med Chem; 2011; 18(17):2566-82. PubMed ID: 21568891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.